Bottom line
How much do HELX and LHCOX overlap?
23% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 32.4% of HELX's assets and 24.1% of LHCOX's. They are substantially different portfolios, so owning both adds real diversification.
Updated Nov 22, 2026
Overlap at a glance
Holdings HELX and LHCOX have in common
| Holding | % of HELX | % of LHCOX | Overlap |
|---|---|---|---|
| Guardant Health Inc GH | 9.09% | 2.61% | 2.61% |
| Natera Inc NTRA | 7.46% | 3.60% | 3.60% |
| Adaptive Biotechnologies Corp ADPT | 3.99% | 1.42% | 1.42% |
| Bridgebio Pharma Inc BBIO | 3.50% | 1.84% | 1.84% |
| Eli Lilly & Company LLY | 2.95% | 10.40% | 2.95% |
| Vertex Pharmaceuticals Inc VRTX | 2.75% | 2.24% | 2.24% |
| Astrazeneca Plc AZN | 2.70% | 1.97% | 1.97% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in HELX
- Krystal Biotech Inc — 6.33%
- Ligand Pharmaceuticals Inc — 4.62%
- United Therapeutics Corp — 3.51%
- Twist Bioscience Corp — 2.85%
- Travere Therapeutics Inc — 2.59%
- Insmed Inc — 2.44%
- Samsung Biologics Co Ltd — 2.26%
- Corteva Inc — 2.25%
- Medpace Holdings Inc — 2.15%
- Alnylam Pharmaceuticals Inc — 1.96%
- Tempus Ai Inc — 1.95%
- Ionis Pharmaceuticals Inc — 1.91%
- Neurocrine Biosciences Inc — 1.84%
- Regeneron Pharmaceuticals Inc — 1.80%
- Veracyte Inc — 1.64%
Only in LHCOX
- UnitedHealth Group Inc — 5.39%
- Johnson & Johnson — 4.96%
- Novartis AG — 4.19%
- Gilead Sciences Inc — 3.53%
- CVS Health Corp — 3.33%
- Galderma Group AG — 2.60%
- Thermo Fisher Scientific Inc — 2.31%
- Cogent Biosciences Inc — 2.27%
- 10X Genomics Inc — 2.16%
- BeOne Medicines Ltd — 2.06%
- Ascendis Pharma A/S — 1.99%
- Madrigal Pharmaceuticals Inc — 1.91%
- Edwards Lifesciences Corp — 1.78%
- Revolution Medicines Inc — 1.67%
- Arrowhead Pharmaceuticals Inc — 1.52%
Asset mix
| Asset type | HELX | LHCOX |
|---|---|---|
| Stocks | 97.9% | 98.2% |
| Repurchase agreements | — | 1.2% |
| Preferred stock | 0.9% | — |
| Cash & short-term funds | — | 0.8% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | HELX | LHCOX |
|---|---|---|
| US | 86.6% | 78.5% |
| CH | 1.2% | 8.8% |
| GB | 3.0% | 2.0% |
| KR | 2.6% | 0.6% |
| DE | 2.2% | — |
| NL | 2.1% | 2.2% |
| DK | — | 2.0% |
| BE | — | 1.4% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do HELX and LHCOX overlap?
What stocks do HELX and LHCOX have in common?
Should I own both HELX and LHCOX?
Which holds more stocks, HELX or LHCOX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.